Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

By Nogueira-Rodrigues Angelica   Moralez Giulliana   Grazziotin Rachele   Carmo Claudio C.   Small Isabele A.   Alves Flavia V.G.   Mamede Marcelo   Erlich Felipe   Viegas Celia   Triginelli Sergio A.   Ferreira Carlos G.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1187-1193

Blackwell Publishing

Access to resources Recommend Favorite

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

By Galanis Evanthia   Buckner Jan   Maurer Matthew   Reid Joel   Kuffel Mary   Ames Matthew   Scheithauer Bernd   Hammack Julie   Pipoly George   Kuross Steven  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 495-503

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

By Ho Cheryl   Davies Angela   Sangha Randeep   Lau Derick   Lara Primo   Chew Helen   Beckett Laurel   Mack Philip   Riess Jonathan   Gandara David  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1587-1591

Springer Publishing Company

Access to resources Recommend Favorite

The Current Status of Combined Radiotherapy and Chemotherapy for Locally Advanced or Resected Pancreas Cancer

By Mulcahy Mary F.   Wahl Andrew O.   Small William  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 5, 2005-09 ,pp. : 637-642

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Phase II trial of dolastatin-10 in patients with advanced breast cancer

By Perez Edith   Hillman David   Fishkin Paul   Krook James   Tan Winston   Kuriakose Phillip   Alberts Steven   Dakhil Shaker  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 257-261

Springer Publishing Company

Access to resources Recommend Favorite